Swiss hearing aid firm Sonova Holding AG said Monday it is buying cochlear implant maker Advanced Bionics Corp., based in California, for $489 million in cash.
Sonova expects the transaction, which is subject to regulatory approval, to be completed within three months.
Privately-held Advanced Bionics was founded in 1993 and is based in Valencia, Los Angeles County. Its majority shareholder is the biotech investor Alfred Mann.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
The company, which has 660 employees and sales in over 30 countries, has an 18 percent share of the global market in cochlear implants. These electronic devices are surgically implanted inside the ear to stimulate the auditory nerves, allowing deaf people to hear sounds.
Sonova spokesman Holger Schimanke said there was little overlap between Sonova and Advanced Bionics, and consequently there are no plans to restructure the business.
Advanced Bionics had a turnover of $117 million last year, a figure which Sonova hopes to double over the coming three to five years, Chapero said.
Analysts reacted cautiously to the announcement, but noted that the purchase of Advanced Bionics represents one of the few M&A opportunities open to Sonova. Two years ago, Germany's anti-cartel agency blocked Sonova's 3.3 billion Swiss franc ($2.76 billion) purchase of Denmark-based ReSound Group.
Zuercher Kantonalbank said the price for Advanced Bionics was high, but judged the purchase as strategic success.
Sonova shares rose 3.1 percent to 112.50 Swiss francs ($111.69) on the Zurich exchange.
Sign up for the free Best Damn Penny Socks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
